1-8 of 8
Alec Goldenberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)

Hun Ju Lee, Michael Y. Choi, Tanya Siddiqi, Joanna M. Rhodes, William G. Wierda, Iris Isufi, Joseph M Tuscano, Nicole Lamanna, Suki Subbiah, Jean L. Koff, Lori Leslie, Alec Goldenberg, Gina G Chung, James B. Breitmeyer, Salim Yazji, Michael Wang, Catriona Jamieson, Thomas J. Kipps
Journal: Blood
Blood (2022) 140 (Supplement 1): 566–568.
https://doi.org/10.1182/blood-2022-167153
Published: 2022
Journal Articles

Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)

Hun Ju Lee, Michael Choi, Tanya Siddiqi, Jacqueline Barrientos, William G. Wierda, Iris Isufi, Joseph Tuscano, Nicole Lamanna, Suki Subbiah, Jean L. Koff, Lori A. Leslie, Alec Goldenberg, Gina G Chung, James B. Breitmeyer, Salim Yazji, Yao Wang, Michael Wang, Catriona Jamieson, Thomas J. Kipps
Journal: Blood
Blood (2021) 138 (Supplement 1): 3534.
https://doi.org/10.1182/blood-2021-148779
Published: 2021
Journal Articles

Cirmtuzumab, an Anti-ROR1 Antibody, in Combination with Ibrutinib: Clinical Activity in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) from a Phase 1/2 Study

Hun Ju Lee, MD, Michael Y. Choi, MD, Tanya Siddiqi, MD, William G. Wierda, MD PhD, Jacqueline C. Barrientos, MD, Nicole Lamanna, MD, Alec Goldenberg, MD, Iris Isufi, MD, Joseph Tuscano, MD, Suki Subbiah, MD, Jean L. Koff, MD, Lori A. Leslie, MD, Gina G Chung, MD, Elizabeth K Weihe, MD, Xen Ianopulos, MD PhD, James B. Breitmeyer, MD PhD, Frank J Hsu, MD, Michael Wang, MD, Catriona Jamieson, MD PhD, Thomas J. Kipps, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-141917
Published: 2020
Journal Articles

Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for CLL and MCL

Michael Y. Choi, MD, Emanuela M. Ghia, PhD, Tanya Siddiqi, MD, William G. Wierda, MD PhD, Hun Ju Lee, Jacqueline C. Barrientos, MD MS, Nicole Lamanna, MD, Alec Goldenberg, Dimitrios Tzachanis, MD PhD, Erin G. Reid, MD MS, Elizabeth K Weihe, MD, Laura Z. Rassenti, PhD, Iris Isufi, MD, Stewart Bieler, BA, Xen Ianopulos, MD PhD, James B. Breitmeyer, MD PhD, Catriona Jamieson, MD PhD, Thomas J. Kipps, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1755.
https://doi.org/10.1182/blood-2019-131498
Published: 2019
Journal Articles

Measurements of Heterogeneity of Bone Marrow Cellularity

Alec Goldenberg, MD, Karen Haglof, MD, Priscilla Kelley, RN, Geri Davis, RN, Cynthia Liu, MD, PhD, Sherif Ibrahim, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4700.
https://doi.org/10.1182/blood.V112.11.4700.4700
Published: 2008
Journal Articles

8 and 11Gauge Bone Marrow Biopsy Needle Performance Characteristics.

Alec Goldenberg, MD, Priscilla Kelley, R.N., Sherif Ibrahim, MD, Filiz Sen, MD, Cynthia Liu, MD
Journal: Blood
Blood (2005) 106 (11): 5580.
https://doi.org/10.1182/blood.V106.11.5580.5580
Published: 2005
Journal Articles

Influence of Age and Needle Gauge on Bone Marrow Biopsy Specimen Adequacy.

Alec Goldenberg, MD, Priscilla Kelley, R.N., Sherif Ibrahim, MD, Filiz Sen, MD, Cynthia Liu, MD
Journal: Blood
Blood (2005) 106 (11): 5581.
https://doi.org/10.1182/blood.V106.11.5581.5581
Published: 2005
Journal Articles

Bone Marrow Biopsy Needle Design Influences the Bone Content of Recovered Specimens.

Alec Goldenberg, M.D., Priscilla Kelley, R.N., Cynthia Liu, M.D., Filiz Sen, M.D., Sherif Ibrahim, M.D.
Journal: Blood
Blood (2004) 104 (11): 5292.
https://doi.org/10.1182/blood.V104.11.5292.5292
Published: 2004